Potential new targets in arthritis therapy: interleukin (IL)‐17 and its relation to tumour necrosis factor and IL‐1 in experimental arthritis

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by chronic joint inflammation and destruction. Interleukin (IL)‐17 is a T cell cytokine expressed in the synovium and synovial fluid of patients with RA. IL‐17 is a potent inducer of various cytokines such as tumour necrosis fa...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Koenders, M I, Joosten, L A B, van den Berg, W B
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2006
Témata:
Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798387/
https://ncbi.nlm.nih.gov/pubmed/17038468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.058529
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky